Improved 24-hour plasma glucose profile in patients with type 2 diabetes treated with Humalog® Mix25™

被引：0
|
作者：
Herz, M
Arora, V
Mollentze, W
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [21] Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System
    Luo, Yong
    Wang, Xue-qin
    Ni, Wen-ji
    Ding, Bo
    Xu, Xiang-hong
    Ye, Lei
    Ma, Jian-hua
    Zhu, Jian
    DIABETES THERAPY, 2018, 9 (06) : 2219 - 2228
  • [22] Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System
    Yong Luo
    Xue-qin Wang
    Wen-ji Ni
    Bo Ding
    Xiang-hong Xu
    Lei Ye
    Jian-hua Ma
    Jian Zhu
    Diabetes Therapy, 2018, 9 : 2219 - 2228
  • [23] 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily
    Guillausseau, PJ
    Greb, W
    DIABETES & METABOLISM, 2001, 27 (02) : 133 - 137
  • [24] Patient preference and willingness-to-pay in five European countries for Humalog Mix25 compared to Humulin 30/70 for the treatment of type 2 diabetes
    Aristides, M
    Weston, A
    FitzGerald, P
    LeReun, C
    Maniadakis, N
    Kielhorn, A
    VALUE IN HEALTH, 2002, 5 (06) : 448 - 448
  • [25] Observation of the differences in parameters of blood glucose fluctuations in patients with type 2 diabetes (T2DM) treated with Humalog Mix 50 and Novo Mix 30
    Li, Ting
    Ma, Jianhua
    Li, Fengfei
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 52 - 52
  • [26] Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients
    Koivisto, VA
    Tuominen, JA
    Ebeling, P
    DIABETES CARE, 1999, 22 (03) : 459 - 462
  • [27] Usefulness of continuous blood glucose monitoring to assess the 24-hour pharmacodynamic profile of a sulfonyurea in type 2 diabetic patients
    Bauduceau, B
    Bailleau, C
    Charbonnel, B
    Gin, H
    Bouhanick, B
    Raccah, D
    Vaur, L
    Halimi, S
    Attali, JR
    DIABETES, 2004, 53 : A471 - A471
  • [28] Mean postprandial and 24-hour glucose are lower with insulin lispro mixture 25/75 compared with insulin glargine in patients with type 2 diabetes mellitus
    Malone, JK
    Roach, P
    DIABETOLOGIA, 2005, 48 : A301 - A302
  • [29] Improved postprandial glycemic control with Humalog® Mix75/25™ after a standard test meal in patients with type 2 diabetes mellitus
    Malone, JK
    Woodworth, JR
    Arora, V
    Yang, HC
    Campaigne, BN
    Hallé, JP
    Yale, JF
    Grossman, LD
    CLINICAL THERAPEUTICS, 2000, 22 (02) : 222 - 230
  • [30] Effects of dapagliflozin (DAPA), a sodium glucose cotransporter 2 inhibitor, on 24-hour glycaemic control in patients with type 2 diabetes
    Mansfield, T.
    Henry, R. R.
    Strange, P.
    Zhou, R.
    Zhuplatov, S. B.
    Klein, D.
    Katz, A.
    DIABETOLOGIA, 2016, 59 : S339 - S339
12345